Literature DB >> 19404306

Atherosclerosis drug fails to meet Phase III trial end point.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19404306     DOI： 10.1038/nrd2879

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

Authors:  Marijn C Meuwese; Eric de Groot; Raphaël Duivenvoorden; Mieke D Trip; Leiv Ose; Frans J Maritz; Dick C G Basart; John J P Kastelein; Rafik Habib; Michael H Davidson; Aeilko H Zwinderman; Lee R Schwocho; Evan A Stein
Journal:  JAMA       Date:  2009-03-18       Impact factor: 56.272
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.